Research & Development

Heptares Therapeutics , the wholly-owned subsidiary of Sosei Group Corporation , describes new insights for drug discovery from the first...

Allergan, a leading global biopharmaceutical company, announced that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on...

Allergan, a leading global biopharmaceutical company, announced today that it has entered into a clinical trial agreement with Novartis to...

Zambon S.p.A., an international pharmaceutical company strongly committed to the central nervous system (CNS) therapeutic area, and Valeo Pharma Inc.,...

Novartis announced today that it has exercised an option to in-license ECF843 for ophthalmic indications worldwide (outside Europe). The closing...

  Sumitomo Dainippon Pharma Co., Ltd. announced that the Company has concluded a license agreement with Bukwang Pharmaceutical Co., Ltd....

Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the EMA and the PMDA in Japan regarding the development...

IBM and Lipscomb University College of Pharmacy announced an initiative to help train the next-generation of pharmacists on business analytics...

Medigene had contracted Mitsui Norin since 2005 for manufacturing and supplying the active pharmaceutical ingredient (API) of Veregen®. Based on...